The role of monoclonal antibodies in smoldering and newly diagnosed transplant-eligible multiple myeloma

HIGHLIGHTS

• who: Zamagni E. et al. from the Dipartimento Area Medica, Università Udine, Udine, Italy have published the paper: The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma, in the Journal: (JOURNAL)
• what: The study is still on-going; a first analysis after enrollment of the first 29 patients showed that the rate of MRD negativity was 83%, with no differences between the two schedules of administration .
• future: Studies are needed to identify the best treatment strategy for HR patients. The ability of MoAbs to induce higher rates of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.